BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago Curaleaf Finalizes Acquisition of Germany's Four 20 Pharma Acquisition European Market Medical Cannabis Curaleaf Holdings Four 20 Pharma
BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago Curaleaf finalise l'acquisition du groupe pharmaceutique allemand Four 20 Pharma. Acquisition Marché Européen Cannabis Médical Curaleaf Holdings Quatre 20 Pharma
BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago Mise à disposition du rapport financier annuel 2025 par HEXAOM Autorité Des Marchés Financiers Hexaom Commissaires Aux Comptes Rapport Financier 2025 Assemblée Générale 2026
BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago Qwamplify : Actualisation du capital et des droits de vote pour mars 2026 PEA-PME Capital Droits De Vote Euronext Growth Qwamplify
BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago HEXAOM makes available its 2025 annual financial report Financial Markets Authority Auditors Hexaom Financial Report 2025 General Assembly 2026
BRIEF published on 04/30/2026 at 22:40, 4 months 11 days ago Qwamplify: Update of share capital and voting rights for March 2026 PEA-PME Voting Rights Capital Euronext Growth Qwamplify
BRIEF published on 04/30/2026 at 22:09, 4 months 11 days ago Interim Financial Statements Released by Sirma Group Holding Financial Statements Investor Relations Transparency Interim Report Sirma Group
BRIEF published on 04/30/2026 at 22:09, 4 months 11 days ago États financiers intermédiaires publiés par Sirma Group Holding Transparence États Financiers Relations Avec Les Investisseurs Rapport Intérimaire Groupe Sirma
BRIEF published on 04/30/2026 at 22:05, 4 months 11 days ago Résultats annuels 2025 de MUNIC : croissance et perspectives Marge Brute EBITDA Ajusté Dette Financière Croissance 2025 Perspectives 2026
BRIEF published on 04/30/2026 at 22:05, 4 months 11 days ago MUNIC's 2025 Annual Results: Growth and Outlook Adjusted EBITDA Gross Margin Financial Debt Growth 2025 Outlook 2026
Published on 09/11/2026 at 23:00, 1 hour 58 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 2 hours 53 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 3 hours 33 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 7 hours 58 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 7 hours 58 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 22:15, 2 hours 43 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 2 hours 48 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 5 hours 13 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 6 hours 43 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 17 hours 58 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 17 hours 58 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 17 hours 58 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 17 hours 58 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 5 hours ago Availability of the 2026 Interim Financial Report
